Afibrinogenemia

Afibrinogenemia (pronounced as a-fib-rin-o-gen-e-mia) is a rare, genetically inherited blood disorder. This condition is characterized by the absence of fibrinogen, a protein in the body that is essential for the blood clotting process.

Etymology

The term "Afibrinogenemia" is derived from the Greek words "a-" meaning "without", "fibrin" meaning "fiber", and "-gen" meaning "producing". The suffix "-emia" is derived from the Greek word "haima" meaning "blood". Thus, the term literally means "without fibrin-producing blood".

Symptoms

People with Afibrinogenemia may experience a variety of symptoms, including bleeding, bruising, and in severe cases, life-threatening hemorrhage. Women with this condition may experience heavy menstrual bleeding and complications during pregnancy.

Diagnosis

Diagnosis of Afibrinogenemia is typically made through blood tests that measure the level of fibrinogen in the blood. Genetic testing may also be used to confirm the diagnosis.

Treatment

Treatment for Afibrinogenemia typically involves replacement therapy with fibrinogen concentrate. This treatment can help to manage bleeding episodes and prevent severe complications.

Related Terms

• Fibrinogen
• Bleeding
• Bruising
• Hemorrhage
• Genetic testing
• Replacement therapy

External links

• Medical encyclopedia article on Afibrinogenemia
• Wikipedia's article - Afibrinogenemia

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski